Vanderbilt Center for Addiction Research, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Brain Res. 2019 Jun 15;1713:1-15. doi: 10.1016/j.brainres.2018.12.024. Epub 2018 Dec 20.
Drug addiction is a major public health concern across the world for which there are limited treatment options. In order to develop new therapies to correct the behavioral deficits that result from repeated drug use, we need to understand the neural circuit dysfunction that underlies the pathophysiology of the disorder. Because the initial reinforcing effects of drugs are dependent on increases in dopamine in reward-related brain regions such as the mesolimbic dopamine pathway, a large focus of addiction research has centered on the dysregulation of this system and its control of positive reinforcement and motivation. However, in addition to the processing of positive, rewarding stimuli, there are clear deficits in the encoding and valuation of information about potential negative outcomes and how they control decision making and motivation. Further, aversive stimuli can motivate or suppress behavior depending on the context in which they are encountered. We propose a model where rewarding and aversive information guides the execution of specific motivated actions through mesocortical and mesolimbic dopamine acting on D1- and D2- receptor containing neuronal populations. Volitional drug exposure alters the processing of rewarding and aversive stimuli through remodeling of these dopaminergic circuits, causing maladaptive drug seeking, self-administration in the face of negative consequences, and drug craving. Together, this review discusses the dysfunction of the circuits controlling different types of aversive learning as well as how these guide specific discrete behaviors, and provides a conceptual framework for how they should be considered in preclinical addiction models.
药物成瘾是全世界范围内一个主要的公共卫生关注点,但目前治疗选择有限。为了开发新的疗法来纠正因反复使用药物而导致的行为缺陷,我们需要了解神经回路功能障碍,这是该疾病病理生理学的基础。由于药物的最初强化作用依赖于中脑边缘多巴胺通路等与奖赏相关的脑区多巴胺的增加,因此成瘾研究的一个主要焦点集中在该系统的失调及其对正强化和动机的控制上。然而,除了对正性、奖赏性刺激的加工外,对于潜在负面结果的信息的编码和估值,以及它们如何控制决策和动机,也存在明显的缺陷。此外,厌恶刺激可以根据其所处的环境来激发或抑制行为。我们提出了一个模型,其中奖赏和厌恶信息通过作用于含有 D1 和 D2 受体的神经元群体的中脑皮质和中脑边缘多巴胺来指导特定动机行为的执行。自愿的药物暴露通过重塑这些多巴胺能回路改变了奖赏和厌恶刺激的加工,导致适应不良的药物寻求、面对负面后果时的自我给药,以及药物渴求。总之,这篇综述讨论了控制不同类型厌恶学习的回路的功能障碍,以及这些回路如何指导特定的离散行为,并为它们在临床前成瘾模型中应如何被考虑提供了一个概念框架。